Biocon Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biocon Limited with three other
pharmaceutical manufacturers in Asia:
Panacea Biotec Ltd
sales of 5.39 billion Indian Rupees [US$83.27 million]
of which 69%
China Regenerative Medicine International Ltd
of Hong Kong
(356.99 million Hong Kong Dollars [US$45.73 million]
of which 51%
was Medical Products and Equipment), and
Pharma Foods International Co.Ltd
based in Japan
(4.72 billion Japanese Yen [US$42.08 million]
Biocon Limited reported sales of 38.91 billion Indian Rupees (US$601.56 million)
March of 2017.
increase of 11.6%
versus 2016, when the company's sales were 34.85 billion Indian Rupees.
Sales at Biocon Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 86%).